J Leg Med. 2020 Jul-Dec;40(3-4):285-291. doi: 10.1080/01947648.2020.1867474.
The landmark symposium, A Decade of the Tobacco Control Act: Progress, Setbacks, and the Future of Tobacco Control, organized by the Public Health Law Center and held in conjunction with the 2019 National Conference on Tobacco or Health, assessed the first 10 years of federal tobacco regulation. In this introduction to the symposium, the Public Health Law Center's executive director provides the context for insights by prominent experts from government, health organizations, and academia, acknowledging the mixed record of U.S. Food and Drug Administration (FDA) regulation to date and suggesting that the agency's ultimate success or failure will be determined by the answers to three fundamental, but still unresolved, questions: What is the true goal of federal regulation? How boldly or cautiously will the FDA approach that goal? And who will the agency serve? The answers to those questions, he argues, will determine the prospects for progress in controlling the nation's leading cause of preventable death.
里程碑式的研讨会“《烟草控制法案》十周年：进展、挫折和烟草控制的未来”由公共卫生法律中心组织，与 2019 年全国烟草或健康会议同时举行，评估了联邦烟草监管的前 10 年。在研讨会的介绍中，公共卫生法律中心的执行主任为来自政府、卫生组织和学术界的知名专家的观点提供了背景，承认美国食品和药物管理局（FDA）监管迄今为止的记录喜忧参半，并表明该机构的最终成功或失败将取决于三个基本但仍未解决的问题的答案：联邦法规的真正目标是什么？FDA 将如何大胆或谨慎地实现这一目标？该机构将为谁服务？他认为，这些问题的答案将决定控制美国可预防死亡的主要原因的进展前景。
